Ingrid Fricke-Galindo

Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality

Yadira Palacios, Andy Ruíz, Lucero A. Ramón‐Luing et al. · International Journal of Molecular Sciences · 2021 · 54 citations · Full text

Immunodeficiencies, Immunology, Renal Inflammation +27

<i>HLA</i>-<i>A*02:01:01</i>/<i>-B*35:01:01</i>/<i>-C*04:01:01</i>Haplotype Associated with Lamotrigine-Induced Maculopapular Exanthema in Mexican Mestizo Patients

Ingrid Fricke-Galindo, Iris E. Martínez‐Juárez, Nancy Monroy‐Jaramillo et al. · Pharmacogenomics · 2014 · 49 citations

Interethnic Variability in <i>CYP2D6</i> , <i>CYP2C9</i> , and <i>CYP2C19</i> Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics

María-Eugenia G. Naranjo, Fernanda Rodrigues‐Soares, Eva Peñas‐Lledó et al. · OMICS A Journal of Integrative Biology · 2018 · 48 citations · Full text

IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19

Ingrid Fricke-Galindo, Alfonso Martínez-Morales, Leslie Chávez‐Galán et al. · Frontiers in Immunology · 2022 · 47 citations · Full text

CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy

Alberto Ortega‐Vázquez, Pedro Dorado, Ingrid Fricke-Galindo et al. · The Pharmacogenomics Journal · 2015 · 30 citations

Plasma Concentrations, Molecular Pharmacology, Mexican-mestizo Patients +7